CCRN - Cross Country Healthcare, Inc.
NASDAQ
->
Healthcare
->
Medical Care Facilities
Boca Raton,
United States
Type: Equity
CCRN price evolution
CCRN
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $69.6 | $5.24 | $17.09 | |
| Short term investments | ||||
| Net receivables | $267.22 | $274.46 | $389.39 | $407.16 |
| Inventory | ||||
| Total current assets | $336.59 | $337.76 | $387.32 | $415.15 |
| Long term investments | ||||
| Property, plant & equipment | $31.68 | $31.67 | $30.03 | $29.94 |
| Goodwill & intangible assets | $184.45 | $187.17 | $189.9 | |
| Total noncurrent assets | $265.13 | $261.12 | $264.16 | |
| Total investments | ||||
| Total assets | $597.42 | $602.88 | $648.44 | $679.32 |
| Current liabilities | ||||
| Accounts payable | $58.44 | $55.68 | $68.92 | $85.33 |
| Deferred revenue | ||||
| Short long term debt | $2.08 | $2.36 | $2.6 | |
| Total current liabilities | $120.68 | $110.11 | $128.44 | $148.59 |
| Long term debt | $2.65 | $2.13 | $2.66 | |
| Total noncurrent liabilities | $53.71 | $51.81 | $57.34 | |
| Total debt | $4.74 | $4.49 | $5.27 | |
| Total liabilities | $172.73 | $163.82 | $180.25 | $205.92 |
| Shareholders' equity | ||||
| Retained earnings | $221.81 | $225 | $241.05 | $238.36 |
| Other shareholder equity | -$1.4 | -$1.39 | -$1.39 | -$1.39 |
| Total shareholder equity | $439.06 | $468.19 | $473.39 | |
| (in millions $) | 31 Dec 2023 | 31 Jan 2023 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Current assets | ||||
| Cash | $17.09 | $3.6 | $1.04 | $1.6 |
| Short term investments | ||||
| Net receivables | $407.16 | $659.96 | $498.95 | $174.7 |
| Inventory | ||||
| Total current assets | $415.15 | $675.67 | $508.27 | $183.11 |
| Long term investments | ||||
| Property, plant & equipment | $29.94 | $22.93 | $23.32 | $22.8 |
| Goodwill & intangible assets | $189.9 | $207.99 | $167.73 | $131.66 |
| Total noncurrent assets | $264.16 | $272.17 | $224.54 | $173.86 |
| Total investments | ||||
| Total assets | $679.32 | $947.84 | $732.81 | $356.97 |
| Current liabilities | ||||
| Accounts payable | $85.33 | $158.45 | $109.75 | $49.88 |
| Deferred revenue | ||||
| Short long term debt | $2.6 | $4.13 | $8.27 | $4.51 |
| Total current liabilities | $148.59 | $271.64 | $199.77 | $93.42 |
| Long term debt | $2.66 | $148.74 | $187.22 | $68.64 |
| Total noncurrent liabilities | $57.34 | $218.98 | $235.51 | $108.64 |
| Total debt | $5.27 | $157.75 | $195.49 | $73.15 |
| Total liabilities | $205.92 | $490.62 | $435.28 | $202.06 |
| Shareholders' equity | ||||
| Retained earnings | $238.36 | $165.73 | -$22.73 | -$154.74 |
| Other shareholder equity | -$1.39 | -$1.39 | -$1.29 | -$1.28 |
| Total shareholder equity | $473.39 | $457.22 | $297.53 | $154.38 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $339.77 | $379.17 | $414.04 | |
| Cost of revenue | $268.97 | $301.88 | $323.55 | |
| Gross Profit | $70.81 | $77.3 | $90.49 | |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $60.26 | $63.25 | $67.57 | |
| Total operating expenses | $90.01 | $74.38 | $77.06 | |
| Operating income | -$19.21 | $2.92 | $13.42 | |
| Income from continuing operations | ||||
| EBIT | -$18.99 | $4.15 | $13.55 | |
| Income tax expense | -$3.51 | $1 | $3.93 | |
| Interest expense | $0.57 | $0.46 | $0.59 | |
| Net income | ||||
| Net income | -$16.05 | $2.69 | $9.04 | |
| Income (for common shares) | -$16.05 | $2.69 | $9.04 | |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Revenue | ||||
| Total revenue | $2019.73 | $2806.61 | $1676.65 | $836.42 |
| Cost of revenue | $1569.32 | $2178.92 | $1301.65 | $633.68 |
| Gross Profit | $450.41 | $627.69 | $375 | $202.73 |
| Operating activities | ||||
| Research & development | ||||
| Selling, general & administrative | $300.39 | $324.21 | $215.29 | $173.81 |
| Total operating expenses | $337.7 | $354.58 | $235.69 | $211.89 |
| Operating income | $112.71 | $273.11 | $139.3 | -$9.16 |
| Income from continuing operations | ||||
| EBIT | $110.99 | $270.72 | $140.07 | -$10.26 |
| Income tax expense | $30.26 | $67.86 | $1.21 | -$0.19 |
| Interest expense | $8.09 | $14.39 | $6.87 | $2.89 |
| Net income | ||||
| Net income | $72.63 | $188.46 | $132 | -$12.96 |
| Income (for common shares) | $72.63 | $188.46 | $132 | -$12.96 |
| (in millions $) | 30 Oct 2024 | 30 Jun 2024 | 31 Mar 2024 | 31 Dec 2023 |
|---|---|---|---|---|
| Net income | -$16.05 | $2.69 | $9.04 | |
| Operating activities | ||||
| Depreciation | $4.95 | $4.88 | $4.76 | |
| Business acquisitions & disposals | ||||
| Stock-based compensation | $2.26 | $1.2 | $1.17 | |
| Total cash flows from operations | $82.4 | $6.01 | $12.07 | |
| Investing activities | ||||
| Capital expenditures | -$2.85 | -$2.21 | -$2.88 | |
| Investments | ||||
| Total cash flows from investing | -$6.18 | -$2.85 | -$2.21 | -$2.88 |
| Financing activities | ||||
| Dividends paid | ||||
| Sale and purchase of stock | -$14.95 | -$6.37 | -$6.4 | |
| Net borrowings | ||||
| Total cash flows from financing | -$42.77 | -$15.19 | -$15.65 | -$6.42 |
| Effect of exchange rate | $0.01 | |||
| Change in cash and equivalents | $46.93 | $64.36 | -$11.85 | $2.79 |
| (in millions $) | 31 Dec 2023 | 31 Dec 2022 | 31 Dec 2021 | 31 Dec 2020 |
|---|---|---|---|---|
| Net income | $72.63 | $188.46 | $132 | -$12.96 |
| Operating activities | ||||
| Depreciation | $19.46 | $14.43 | $12.28 | $16.22 |
| Business acquisitions & disposals | -$35.18 | -$26.88 | ||
| Stock-based compensation | $6.58 | $7.39 | $6.89 | $5.4 |
| Total cash flows from operations | $248.5 | $134.05 | -$85.62 | $27.2 |
| Investing activities | ||||
| Capital expenditures | -$13.97 | -$8.79 | -$7.17 | -$4.62 |
| Investments | ||||
| Total cash flows from investing | -$13.78 | -$43.87 | -$34.05 | -$4.62 |
| Financing activities | ||||
| Dividends paid | -$1.15 | |||
| Sale and purchase of stock | -$57.65 | -$35.28 | ||
| Net borrowings | -$150.68 | -$38.5 | $121.58 | -$20.07 |
| Total cash flows from financing | -$221.24 | -$87.6 | $119.09 | -$22.01 |
| Effect of exchange rate | $0.01 | -$0.01 | $0.01 | -$0.01 |
| Change in cash and equivalents | $13.49 | $2.57 | -$0.56 | $0.57 |
News
Fundamentals
| Market cap | $589.56M |
|---|---|
| Enterprise value | N/A |
| Shares outstanding | 32.57M |
| Revenue | N/A |
|---|---|
| EBITDA | N/A |
| EBIT | N/A |
| Net Income | N/A |
| Revenue Q/Q | N/A |
| Revenue Y/Y | N/A |
| P/E ratio | N/A |
|---|---|
| EV/Sales | N/A |
| EV/EBITDA | N/A |
| EV/EBIT | N/A |
| P/S ratio | N/A |
| P/B ratio | N/A |
| Book/Share | N/A |
| Cash/Share | N/A |
| EPS | N/A |
|---|---|
| ROA | N/A |
| ROE | N/A |
| Debt/Equity | 0.43 |
|---|---|
| Net debt/EBITDA | N/A |
| Current ratio | 2.79 |
| Quick ratio | N/A |